Screener
Janux Therapeutics JANX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Janux Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:18 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338078
| Assets | June 30,2026 / (unaudited) | December 31,2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value; authorized shares – 10,000,000 at June 30, 2026 and December 31, 2025, respectively; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value; authorized shares – 200,000,000 at June 30, 2026 and December 31, 2025; issued and outstanding shares – 61,077,980 and 60,384,283 at June 30, 2026 and December 31, 2025, respectively | 61 | 60 |
| Additional paid-in capital | 1,327,943 | 1,303,828 |
| Accumulated other comprehensive income (loss) | (2,305) | 4,316 |
| Accumulated deficit | (397,715) | (351,382) |
| Total stockholders’ equity | 927,984 | 956,822 |
| Total liabilities and stockholders’ equity | $1,007,653 | $1,001,565 |
Item 1. Financial Statements.
FAQ
- What is Janux Therapeutics's total liabilities & equity?
- Janux Therapeutics (JANX) reported total liabilities & equity of $1.01B in Q2 2026.
- How has Janux Therapeutics's total liabilities & equity changed year-over-year?
- Janux Therapeutics's total liabilities & equity decreased by 2.4% year-over-year, from $1.03B to $1.01B.
- What is the long-term trend for Janux Therapeutics's total liabilities & equity?
- Over 5 years (2020 to 2025), Janux Therapeutics's total liabilities & equity has grown at a 128.1% compound annual growth rate (CAGR), from $16.22M to $1B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Janux Therapeutics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude